The PI3K-AKT-mTOR signaling axis—one of the most frequently deregulated pathways in prostate cancer—contributes to tumor growth and therapy resistance by regulating cell proliferation, survival, and metabolic reprogramming. This evidence concerns the gene AKT1 and prostate cancer.